Small interfering RNA targets VEGF for exudative AMD

Miami-Treatment with small interfering RNA (siRNA) directed against vascular endothelial growth factor (VEGF) is showing promise as a new therapy for choroidal neovascularization (CNV), according to Michael J. Tolentino, MD, who spoke at Angiogenesis 2004.

Related Videos
View All
Related Content
© 2023 MJH Life Sciences

All rights reserved.